Development of a STAT5 Phosphorylation Assay as a Rapid Bioassay to Assess Interleukin-7 Potency

被引:1
作者
Zumpe, C. [1 ,2 ]
Engel, K. [1 ]
Wiedemann, N. [1 ]
Metzger, A. U. [1 ]
Pischetsrieder, M. [2 ]
Bachmann, C. L. [1 ]
机构
[1] Merck KGaA, Analyt Dev Biotech Prod, Darmstadt, Germany
[2] Univ Erlangen Nurnberg, Inst Pharm & Food Chem, D-91054 Erlangen, Germany
关键词
Bioassay; interleukin-7; kit; 225; cells; phosphorylation assay; proliferation assay; quality control; STAT5; PRIMARY HUMAN T; PHOSPHATIDYLINOSITOL; 3-KINASE; ACTIVATION; RECEPTOR; KINASES; IL-7; ASSOCIATION; PROTEINS; INDUCE; ROLES;
D O I
10.2174/138920111798357294
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin (IL)-7 is a cytokine inducing the Janus Kinase (JAK)/Signal Transducer and Activator of Transcription (STAT) pathway. As a consequence of IL-7 activating this pathway, STAT5 is phosphorylated. In pharmaceutical quality control, the potency of biopharmaceuticals is commonly assessed by proliferation assays. This is also possible for IL-7 conjugates. However, the disadvantage of these classical "endpoint-assays" is that they require very long incubation times, up to several days, since they measure the downstream events of a cellular response. As an alternative to this, we developed a rapid intracellular phosphorylation assay, measuring IL-7 induced STAT5 phosphorylation in Kit 225 cells. The Kit 225 human T cell line expresses the IL-7 receptor and is responsive to IL-7, therefore making it a good candidate cell line for assay development. Like the Kinase receptor activation (KIRA) assay, developed by Sadick et al. [1], the STAT5 phosphorylation assay was performed using two separate microtiter plates: the first one for cell stimulation and lysis, the second one for enzyme-linked immuno sorbent assay (ELISA). The assay showed a high accuracy and precision with a mean recovery of 102% and a mean coefficient of variation of 9%. In comparison to the classical proliferation assay, the phosphorylation assay is much faster. Thus, the assay procedure time can at least be reduced from six to three days by using STAT5 phosphorylation instead of proliferation as an endpoint due to the shorter incubation time with IL-7. Moreover, the phosphorylation assay shows a wider dynamic range and higher signal to noise ratios and is thus more robust than the proliferation assay. mAs a consequence, this assay could serve as reliable, accurate, precise and fast alternative to the classical proliferation assay for IL-7. This study also serves as an example for the typical steps during development and qualification/validation of a potency assay for quality control testing.
引用
收藏
页码:1580 / 1588
页数:9
相关论文
共 28 条
  • [1] Phosphorylation of Grb2-associated binder 2 on serine 623 by ERK MAPK regulates its association with the phosphatase SHP-2 and decreases STAT5 activation
    Arnaud, M
    Cronin, C
    Deon, C
    Loyaux, D
    Bertoglio, J
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (06) : 3962 - 3971
  • [2] Disruption of Akt kinase activation is important for immunosuppression induced by measles virus
    Avota, E
    Avots, A
    Niewiesk, S
    Kane, LP
    Bommhardt, U
    ter Meulen, V
    Schneider-Schaulies, S
    [J]. NATURE MEDICINE, 2001, 7 (06) : 725 - 731
  • [3] Optimization and utilization of the SureFire phospho-STAT5 assay for a cell-based screening campaign
    Binder, Christina
    Lafayette, Amy
    Archibeque, Ivonne
    Sun, Yu
    Plewa, Cherylene
    Sinclair, Angus
    Emkey, Renee
    [J]. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2008, 6 (01) : 27 - 37
  • [4] Anti-apoptotic role of STAT5 in haematopoietic cells and in the pathogenesis of malignancies
    Debierre-Grockiego, F
    [J]. APOPTOSIS, 2004, 9 (06) : 717 - 728
  • [5] Delespine-Carmagnat M, 2000, EUR J IMMUNOL, V30, P59, DOI 10.1002/1521-4141(200001)30:1<59::AID-IMMU59>3.3.CO
  • [6] 2-T
  • [7] INTERLEUKIN-7 CAN INDUCE THE ACTIVATION OF JAK-1, JAK-3 AND STAT-5 PROTEINS IN MURINE T-CELLS
    FOXWELL, BMJ
    BEADLING, C
    GUSCHIN, D
    KERR, I
    CANTRELL, D
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (11) : 3041 - 3046
  • [8] STAT5 activation underlies IL7 receptor-dependent B cell development
    Goetz, CA
    Harmon, IR
    O'Neil, JJ
    Burchill, MA
    Farrar, MA
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (08) : 4770 - 4778
  • [9] GOODWIN RG, 1990, YEAR IMMUNOLOGY, V6, P127
  • [10] EBF-regulating Pax5 transcription is enhanced by STAT5 in the early stage of B cells
    Hirokawa, S
    Sato, H
    Kato, B
    Kudo, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (07) : 1824 - 1829